Key Highlights
•
A study comparing two common data models (OMOP and ConcePTION) for analyzing real-world patient data found that the choice of model can change the apparent safety and effectiveness of blood thinners. This highlights a major challenge for drug safety research, showing that the digital tools used to analyze health records can directly influence the conclusions doctors and regulators see.
Source →
•
Researchers discovered that the type of nanoparticle used to deliver the cancer drug paclitaxel significantly changes its molecular effects and its ability to block the growth of new blood vessels that feed tumors. This means that improving cancer treatment isn’t just about the drug itself, but also about the microscopic “delivery vehicle” that carries it.
Source →
•
A new drug screening method using 3D models of brain tumors called organoids identified that the existing drug panobinostat, which targets proteins HDAC1 and HDAC2, is a promising treatment for meningiomas. This offers a faster path to new treatments by repurposing an already-known drug for a different type of cancer.
Source →
•
A 12-month trial found that progressive resistance training (weight lifting) led to a small but measurable improvement in cognitive function for older adults with early vascular cognitive impairment, especially in women. This provides evidence that physical exercise can be a direct treatment to help slow down memory and thinking problems linked to small blood vessel disease in the brain.
Source →
•
A review explains how MRI technology can now be used to create maps of tissue electrical conductivity, revealing details about the body’s microstructure and composition without any needles or surgery. This new type of scan could become a routine part of MRI exams, giving doctors a more precise tool for diagnosis and monitoring treatment.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
